The Committee adopted by consensus positive opinions for extension of the existing authorisations for Inflacam (meloxicam), from Chanelle Pharmaceuticals Manufacturing Limited to include 5 mg/ml solution for injection for cattle and pigs, and Rheumocam (meloxicam), from Chanelle Pharmaceuticals Manufacturing Limited to include 5 mg/ml solution for injection for cattle and pigs.
Go to Source

This entry was posted on Saturday, October 13th, 2012 at 11:31 pm and is filed under European Medicines Agency. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.